Physician profile
Allan Akerman
NPI 1396714184
$62,921.82
in general payments reported to CMS, 2019-2025
41 companies · $627 in 2025
The $627 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $16K · 2021: $8,273 · 2022: $5,863 · 2023: $743 · 2024: $455 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.04 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $51,142.53 | 2019-2024 | Lo Loestrin Fe, Liletta, Orilissa |
| Aspira Women'S Health INC | $6,426.69 | 2019-2024 | Ova1 |
| Covidien LP | $1,000.00 | 2019 | |
| Ethicon INC. | $987.15 | 2019 | |
| Allergan, INC. | $382.35 | 2019-2020 | |
| Avion Pharmaceuticals | $233.63 | 2020-2022 | |
| Astellas Pharma US INC | $204.46 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $200.82 | 2023-2025 | Myfembree, Gemtesa |
| Coopersurgical, INC. | $198.36 | 2019-2025 | Paragard T 380a, Endosee, Paragard T 380a |
| Evofem Biosciences, INC. | $190.89 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $167.86 | 2019-2025 | |
| Exeltis, USA INC. | $165.27 | 2019-2023 | Slynd |
| Minerva Surgical, INC | $149.18 | 2019-2024 | |
| Roche Diagnostics Corporation | $144.57 | 2019-2020 | |
| Becton, Dickinson and Company | $127.42 | 2019-2024 | Bd Onclarity |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $122.71 | 2022-2024 | Aptima |
| Myovant Sciences INC. | $104.94 | 2021-2022 | |
| Pfizer INC. | $98.41 | 2022-2024 | |
| Agile Therapeutics, INC. | $91.66 | 2021-2024 | Twirla |
| Coloplast Corp | $79.34 | 2021-2025 | |
| Therapeuticsmd, INC. | $67.38 | 2020 | |
| Caldera Medical, INC | $62.32 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.98 | 2019-2025 | |
| Novo Nordisk INC | $56.79 | 2025 | Wegovy |
| Channel Medsystems, INC. | $43.65 | 2022-2023 | |
| Medicem INC. | $42.09 | 2021-2022 | |
| Millicent US INC | $41.63 | 2025 | Femlyv, Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $39.49 | 2019-2021 | |
| Exact Sciences Corporation | $34.11 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $27.32 | 2025 | Zepbound, Mounjaro |
| Biogen, INC. | $27.10 | 2025 | Zurzuvae |
| Dysis Medical, INC. | $27.03 | 2021-2022 | |
| Ethicon US, LLC | $26.31 | 2019 | |
| Organon LLC | $24.52 | 2021-2024 | |
| Ascend Therapeutics US, LLC | $24.00 | 2024 | |
| Sage Therapeutics, LLC | $23.18 | 2019 | |
| Intuitive Surgical, INC. | $22.76 | 2020 | |
| Vertical Pharmaceuticals, LLC | $16.49 | 2019 | |
| Meditrina | $14.15 | 2025 | |
| Daiichi Sankyo INC. | $11.72 | 2019 | |
| Zyla Life Sciences, INC. | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Akerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.